Reuters logo
BRIEF-Melinta Therapeutics says first patient treated in mid-stage study of topical drug for acne
November 13, 2017 / 12:09 PM / 9 days ago

BRIEF-Melinta Therapeutics says first patient treated in mid-stage study of topical drug for acne

Nov 13 (Reuters) - Melinta Therapeutics, Inc.-

* Melinta Therapeutics reports first patient treated in Phase 2 study of topical radezolid for treatment of acne Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below